Dr. Scott Stewart
Assistant Professor, Department of Psychiatry and Behavioral Sciences
Assistant Professor, Department of Medicine |
Research Interests Dr. Stewart’s research interests generally include detection and treatment of alcohol-related disorders in medical and surgical settings. His particular focus is on novel biomarker validation in relevant clinical populations, the integration of biomarkers with self-report screening instruments, and identification of biomarkers for specific alcohol-related conditions. Education | Geneva College, Beaver Falls, PA | B.S. | 1987 | Chemistry | | Baylor University, Waco, TX | | 1989 | Biochemistry | | Temple University, Philadelphia, PA | M.D. | 1993 | Medicine | | University of Pittsburgh, Pittsburgh, PA | | 1996 | Internal Medicine | | Medical University of South Carolina, Charleston, SC | M.S. | 2001 | Clinical Research |
Professional Experience | 1993-1996 | Intern and Resident, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA | | 1996-1999 | Staff Physician, Central Maine Medical Center, Lewiston, ME | | 1996-1999 | General Internist, L-A Internal Medicine Associates, PA, Auburn, ME | | 1999-2001 | Academic Generalist Fellow, Center for Healthcare Research and Division of General Internal Medicine, MUSC, Charleston, SC | | 2001-2006 | Assistant Professor, Department of Medicine, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY | | 2006-present | Assistant Professor, Department of Psychiatry, and Department of Medicine, MUSC, Charleston, SC |
Professional Societies and Certification | 1996-present | Member, American College of Physicians | | 1999-present | Member, Society of General Internal Medicine | | 2002-present | Member, Research Society on Alcoholism | | 2006 | Diplomate, American Board of Internal Medicine | | 2007 | Field Reviewer, Substance Abuse Treatment Improvement Protocol Series, Center for Substance Abuse Treatement (CSAT), Substance Abuse Mental Health Services Administration (SAMHSA), United States Department of Health and Human Services (HHS) | | 2007 | Invited speaker and discussant on alcohol biomarkers, Team on Underage Drinking Research-Screening for Childhood and Adolescent Drinking and Alcohol Use Disorders Among Youth, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD | | 2007 | Editorial Consultant, Alcohol Abuse Module, Physicians' Information and Education Resource (PIER), American College of Physicians |
Recent Publications
Anton RF, Myrick H, Baros AM, Latham PK, Randall PK, Wright TM, Stewart SH, Waid R & Malcolm R. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: Relationship to alcohol withdrawal symptoms. Journal of Clinical Psychopharmacology 29(4):334-342, 2009. Stewart SH. Dependence and Diagnosis. In Evidence-Based Addiction Treatment, Miller PM (Ed) pp 77-88. Academic Press, New York, NY, 2009. Stewart SH, Oroszi G, Randall PK & Anton RF. COMT genotype influences the effect of alcohol on blood pressure: Results from the COMBINE study. American Journal of Hypertension 22(1):87-91, 2009. PMCID: PMC2630169 Stewart SH, Reuben A, Brzezinski WA, Koch DG, Basile J, Randall PK & Miller PM. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol and Alcoholism 44(5):464-467, 2009. PMCID: PMC2765354 Stewart SH, Goldmann A, Neumann T & Spies C. Biomarkers of Alcohol and Other Drug Use. In Addiction Research Methods, Miller PG, Strang J, Miller PM (Eds). Wiley-Blackwell Publishing, Malden, MA, 2010. |
